CNA Financial Corporation (CNA) Stock Price & How to Invest

CNA Financial Corporation is an insurance holding company that writes commercial property and casualty coverage, including specialty lines, standard commercial insurance, and international business, largely for businesses rather than individuals. Its earnings come from two engines: underwriting profit (premiums collected versus claims and expenses, tracked through the combined ratio) and net investment income earned on a large bond-heavy portfolio. Loews Corporation owns roughly 90% of the shares, so CNA operates as the primary insurance subsidiary within that conglomerate.

The investment picture is one of stability and income rather than rapid growth. CNA posted full-year 2025 net income of about $4.69 per share and a property and casualty combined ratio of roughly 94.7% (below 100% means underwriting profit), with mid-single-digit net written premium growth. The stock is known for a sizable dividend program that combines a regular quarterly payout with periodic special dividends, which pushes its headline yield well above most insurers. The main caveats are a very high parent ownership stake that limits float and public influence, and sensitivity to catastrophe losses, reserve adequacy, and interest rates.

2026 has been a softer underwriting year. The first quarter brought core income of $0.83 per share against a consensus near $1.24, with a P&C combined ratio of 102.2% that included 4.1 points of unfavorable prior-period reserve development in excess casualty and professional E&O lines. The second quarter recovered to core income of $1.19 per share, above the $1.05 estimate, but the P&C combined ratio was still 96.5% (94.2% underlying, up from 91.7% a year earlier) and Corporate and Other took a $77 million after-tax charge for legacy mass tort. Net written premiums grew 4% in the quarter and net investment income rose to $701 million. Book value per share was $41.34 at June 30, 2026 ($45.83 excluding AOCI). The shares are up about 2% in 2026 and 6% over twelve months, and third-quarter results are due November 2, 2026, with consensus core EPS near $1.13.

CNA is exposed to catastrophe losses (hurricanes, wildfires, severe storms) that can spike the combined ratio in any given quarter, as well as the risk that prior-year reserves prove inadequate for long-tail casualty claims, a risk that showed up in 2026 through 4.1 points of adverse development in excess casualty and professional E&O in the first quarter and a $77 million after-tax legacy mass tort charge in the second. Its heavy fixed-income portfolio makes book value and investment income sensitive to interest-rate and credit-spread swings. The special dividends are discretionary and could shrink or disappear in a weaker year, which would hit the total-return thesis. The roughly 90% Loews ownership limits public float and minority-holder influence, and any conflict between parent and minority interests is a structural consideration. Broad commercial-insurance pricing cycles turning softer would pressure premium growth and margins. Analyst consensus expects 2026 core EPS of about $4.20, down roughly 15% from 2025, before a rebound to about $4.80 in 2027.

We give no verdict on CNA Financial Corporation. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Commercial P&C pricing and underwriting discipline. CNA's core earnings depend on writing commercial and specialty coverage at profitable rates, reflected in a combined ratio that ran in the mid-90s through 2025.

The case against. CNA is exposed to catastrophe losses (hurricanes, wildfires, severe storms) that can spike the combined ratio in any given quarter, as well as the risk that prior-year reserves prove inadequate for long-tail casualty claims, a risk that showed up in 2026 through 4.1 points of adverse development in excess casualty and professional E&O in the first quarter and a $77 million after-tax legacy mass tort charge in the second.

Read the full bull and bear case on CNA, including what would have to change to break either one. Walnut is not an investment adviser.

No. CNA Financial Corporation (CNA) has not split its stock in the last 10 years. That is a statement about the window we check rather than about the company’s entire history, so an older split is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see CNA Financial Corporation's investor relations page or your broker.

• Market cap: ~$13B
• Revenue (TTM): ~$15.2B
• Net income (TTM): ~$1.24B (~$4.49/sh)
• P&C combined ratio (Q2 2026): ~96.5% (underlying ~94.2%)
• P/E (trailing / forward): ~10.7x / ~10x
• Book value per share (Jun 30, 2026): ~$41.34 (~$45.83 ex-AOCI); ~1.16x book
• Dividend yield: ~4% regular; ~8% including the $2.00 special

At about $47.87 on October 16, 2026, CNA trades near 10.7x trailing earnings and roughly 1.16x book value, a modest multiple for a mature commercial insurer whose 2026 underwriting margins have slipped. Consensus calls for core EPS near $4.20 in 2026 and $4.80 in 2027, with third-quarter results due November 2. The eye-catching yield reflects both the regular quarterly dividend and recurring special dividends rather than a distressed valuation, and roughly 90% Loews ownership means the small public float can amplify price moves.

Other names that sit close to CNA: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get CNA exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so CNA sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where CNA fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

CNA is a slow-moving, income-oriented commercial insurer whose appeal rests on underwriting discipline and a large dividend, with the trade-off of a controlling parent and thin public float.

Whether CNA is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is CNA a buy or a sell?, and where the stock could go from here in the CNA stock forecast.

For income investors, whether CNA pays a dividend and how the payout looks is covered in does CNA pay a dividend? And to weigh CNA against a peer, read the full side-by-side comparisons: CNA vs CB and CNA vs CINF.